AlphaGrep UK’s Astera Labs ALAB Stock Holding History

AlphaGrep UK’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,091	Closed	-$339K	–	989
2026 Q1	$339K	Buy	+3,091	New	+$440K	0.1%	452

Other funds holding ALAB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

AlphaGrep UK's ALAB Position: Q2 2026 in Review

AlphaGrep UK sold out of Astera Labs (ALAB) in Q2 2026, closing a stake of 3,091 shares — an estimated $339K sold.

AlphaGrep UK first reported a position in ALAB in Q1 2026 and held it in 1 quarter. The position peaked at $339K in Q1 2026. 918 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

AlphaGrep UK reported no remaining Astera Labs position as of Q2 2026 after selling out during the quarter.
AlphaGrep UK sold 3,091 Astera Labs shares in Q2 2026, an estimated $339K.
AlphaGrep UK first reported a position in Astera Labs in Q1 2026 and held it in 1 quarter.
AlphaGrep UK's Astera Labs position peaked at $339K in Q1 2026.
918 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.